Developments Hancock Jaffe implants four VenoValves in first-in-human study Hancock Jaffe (NASDAQ:HJLI) has implanted VenoValves in four patients with severe, chronic venous insufficiency (CVI) as part of its first-in-human study of the device. CVI occurs when the valves in the veins of the leg... April 11, 2019